MedPath

The Effect of Heart Rate Variability Biofeedback Training on Health of Intrapartum Women

Not Applicable
Completed
Conditions
Mental Stress
Interventions
Device: heart rate variability biofeedback Application (Eureka iDestressor)
Registration Number
NCT04830111
Lead Sponsor
National Taipei University of Nursing and Health Sciences
Brief Summary

In this study, the investigators examined the efficacy of heart rate variability biofeedback on physical and mental health problems in childbirth women.

Detailed Description

In this study, the investigators examined the efficacy of heart rate variability biofeedback on physical and mental health problems in childbirth women. The following validated self-report measures were administered before and at five days after the intervention, Perceived stress scale-10, Beck Anxiety Inventory, and Edinburgh Postnatal Depression Scale.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
82
Inclusion Criteria
  • woman
  • aged 20 years or more
  • able to understand and write Chinese
  • singleton birth
  • having a full-term and healthy newborn
Exclusion Criteria
  • suicidal ideations
  • psychosis
  • medical or obstetric complications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
heart rate variability biofeedback training groupheart rate variability biofeedback Application (Eureka iDestressor)The goal of heart rate variability biofeedback is to increase heart rate variability through paced breathing exercises, which have shown to be effective in reducing stress and anxiety in general adult populations.
Primary Outcome Measures
NameTimeMethod
Stress variablebaseline on childbirth first day (before the intervention) .

The Perceived Stress Scale using 10 items to determine the self-perceived levels of unpredictability, lack of control, and burden during the last month of pregnancy. Responses are rated from 0 (never) to 4 (very often), with higher scores corresponding to higher perceived stress.

Depression variablebaseline on childbirth first day (before the intervention).

The Edinburgh Postnatal Depression Scale was using 10 items to provide a valuable and efficient way to identify patients at risk of perinatal depression. Each item is scored from 0 to 3, with item scores summed to produce a total The Edinburgh Postnatal Depression Scale was using 10 items to provides a valuable and efficient way to identify patients at risk of perinatal depression. Each item is scored from 0 to 3, with higher scores corresponding to higher depression.

Anxiety variablebaseline on childbirth first day (before the intervention).

The Beck Anxiety Inventory using 21 items on the scale describes a symptom of anxiety. Responses are rated from 0 (never) to 3 (very often), with higher scores corresponding to higher perceived anxiety.

Secondary Outcome Measures
NameTimeMethod
Stress variableon childbirth fifth day (after the intervention)

The Perceived Stress Scale using 10 items to determine the self-perceived levels of unpredictability, lack of control, and burden during the last month of pregnancy. Responses are rated from 0 (never) to 4 (very often), with higher scores corresponding to higher perceived stress.

Anxiety variableon childbirth fifth day (after the intervention)

The Beck Anxiety Inventory using 21 items on the scale describes a symptom of anxiety. Responses are rated from 0 (never) to 3 (very often), with higher scores corresponding to higher perceived anxiety.

Depression variableon childbirth fifth day (after the intervention)

The Edinburgh Postnatal Depression Scale was using 10 items to provide a valuable and efficient way to identify patients at risk of perinatal depression. Each item is scored from 0 to 3, with item scores summed to produce a total The Edinburgh Postnatal Depression Scale was using 10 items to provides a valuable and efficient way to identify patients at risk of perinatal depression. Each item is scored from 0 to 3, with higher scores corresponding to higher depression.

Trial Locations

Locations (1)

Wan-Lin Pan

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath